Unrecognized Tax Benefits of RIGEL PHARMACEUTICALS INC from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
RIGEL PHARMACEUTICALS INC quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • RIGEL PHARMACEUTICALS INC Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $9,050,000, a 3.1% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

RIGEL PHARMACEUTICALS INC Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $9,050,000 +$270,000 +3.1% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q4 2024 $8,780,000 +$108,000 +1.2% 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q4 2023 $8,672,000 -$754,000 -8% 31 Dec 2023 10-K 03 Mar 2026 2025 FY
Q4 2022 $9,426,000 +$240,000 +2.6% 31 Dec 2022 10-K 03 Mar 2026 2025 FY
Q4 2021 $9,186,000 +$285,000 +3.2% 31 Dec 2021 10-K 04 Mar 2025 2024 FY
Q4 2020 $8,901,000 +$543,000 +6.5% 31 Dec 2020 10-K 05 Mar 2024 2023 FY
Q4 2019 $8,358,000 $0 0% 31 Dec 2019 10-K 07 Mar 2023 2022 FY
Q4 2018 $8,358,000 +$928,000 +12% 31 Dec 2018 10-K 01 Mar 2022 2021 FY
Q4 2017 $7,430,000 +$527,000 +7.6% 31 Dec 2017 10-K 27 Feb 2020 2019 FY
Q4 2016 $6,903,000 -$10,375,000 -60% 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q4 2015 $17,278,000 +$11,904,000 +222% 31 Dec 2015 10-K 06 Mar 2018 2017 FY
Q4 2014 $5,374,000 +$373,000 +7.5% 31 Dec 2014 10-K 07 Mar 2017 2016 FY
Q4 2013 $5,001,000 +$701,000 +16% 31 Dec 2013 10-K 08 Mar 2016 2015 FY
Q4 2012 $4,300,000 +$2,800,000 +187% 31 Dec 2012 10-K 03 Mar 2015 2014 FY
Q4 2011 $1,500,000 $0 0% 31 Dec 2011 10-K 04 Mar 2014 2013 FY
Q4 2010 $1,500,000 31 Dec 2010 10-K 05 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.